Specific and common genes implicated across major mental disorders: A review of meta-analysis studies

Journal of Psychiatric Research

Volumn 60, Issue , 2015, Pages 1-13

  Gatt, Justine M ^a,b,c,d   Burton, Karen L O ^a,b,c,d   Williams, Leanne M ^a,e   Schofield, Peter R ^c,d  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

^c NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Genotype; GWAS; Mental illness; Meta analysis; Pleiotrophy; Review; TWIN E

Indexed keywords

ALLELE; ANXIETY DISORDER; ASIAN; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; CARDIOVASCULAR SYSTEM; CAUCASIAN; COGNITION; DOPAMINERGIC SYSTEM; EMOTION; ETHNICITY; GENETIC ASSOCIATION; GENETIC VARIABILITY; HEREDITY; HUMAN; MAJOR DEPRESSION; MENTAL DISEASE; META ANALYSIS; OBSESSIVE COMPULSIVE DISORDER; PANIC; REVIEW; SCHIZOPHRENIA; SEROTONINERGIC SYSTEM; SOUTH AMERICAN; ADULT; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM;

ACE PROTEIN, HUMAN; APOLIPOPROTEIN E; BRAIN DERIVED NEUROTROPHIC FACTOR; CATECHOL METHYLTRANSFERASE; COMT PROTEIN, HUMAN; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ANXIETY DISORDERS; APOLIPOPROTEINS E; BIPOLAR DISORDER; BRAIN-DERIVED NEUROTROPHIC FACTOR; CATECHOL O-METHYLTRANSFERASE; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA;

EID: 84919385896     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2014.09.014     Document Type: Review

References (152)

1. Abdolmaleky H.M., Faraone S.V., Glatt S.J., Tsuang M.T. Meta-analysis of association between the T102C polymorphism of the 5HT2a receptor gene and schizophrenia. Schizophr Res 2004, 67:53-62.
2. Alba-Ferrara L., De Erausquin G.A. What does anisotropy measure? Insights from increased and decreased anisotropy in selective fiber tracts in schizophrenia. Front Integr Neurosci 2013, 7.
3. Aleman A., Kahn R.S., Selten J.P. Sex differences in the risk of schizophrenia - evidence from meta-analysis. Arch Gen Psychiatry 2003, 60:565-571.
4. Allen N.C., Bagade S., McQueen B., Ioannidis J.P.A., Kavvoura F.K., Khoury M.J., et al. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet 2008, 40:827-834.
5. Andreou D., Saetre P., Werge T., Andreassen O.A., Agartz I., Sedvall G.C., et al. D-amino acid oxidase activator gene (DAOA) variation affects cerebrospinal fluid homovanillic acid concentrations in healthy Caucasians. Eur Arch Psychiatry Clin Neurosci 2012 Oct, 262(7):549-556. 10.1007/s00406-012-0313-z.
6. Azzam A., Mathews C.A. Meta-analysis of the association between the catacholamine-O-methyl-transferase gene and obsessive-compulsive disorder. Am J Med Genet Part B: Neuropsychiatr Genet 2003, 123B:64-69.
7. Baum A.E., Hamshere M., Green E., Cichon S., Rietschel M., Noethen M.M., et al. Meta-analysis of two genome-wide association studies of bipolar disorder reveals important points of agreement. Mol Psychiatry 2008, 13:466-469.
8. Belfer M.L. Child and adolescent mental disorders: the magnitude of the problem across the globe. JChild Psychol Psychiatry 2008, 49:226-236.
9. Burmeister M., McInnis M.G., Zollner S. Psychiatric genetics: progress amid controversy. Nat Rev Genet 2008, 9:527-540.
10. Cantor R.M., Lange K., Sinsheimer J.S. Prioritizing GWAS results: a review of statistical methods and recommendations for their application. Am J Hum Genet 2010, 86:6-22.
11. Carlson S.R., Iacono W.G. Heritability of P300 amplitude development from adolescence to adulthood. Psychophysiology 2006, 43:470-480.
12. Chanock S.J., Manolio T., Boehnke M., Boerwinkle E., Hunter D.J., Thomas G., et al. Replicating genotype-phenotype associations. Nature 2007, 447:655-660.
13. Chen J.S., Lipska B.K., Halim N., Ma Q.D., Matsumoto M., Melhem S., et al. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 2004, 75:807-821.
14. Chen Z., Liu Y., Zhang D., Liu Z., Wang P., Zhou D., et al. C677T methylenetetrahydrofolate reductase gene polymorphisms in bipolar disorder: an association study in the Chinese population and a meta-analysis of genetic association studies. Neurosci Lett 2009, 449:48-51.
15. Cohen-Woods S., Craig I., Gaysina D., Gray J., Gunasinghe C., Craddock N., et al. The Bipolar Association Case-Control Study (BACCS) and meta-analysis: no association with the 5,10-Methylenetetrahydrofolate reductase gene and bipolar disorder. Am J Med Genet Part B: Neuropsychiatr Genet 2010, 153B:1298-1304.
16. Collaer M.L., Hines M. Human behavioral sex differences: a role for gonadol hormones during early development?. Psychol Bull 1995, 118:55-107.
17. Conner J.M., Lauterborn J.C., Yan Q., Gall C.M., Varon S. Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport. JNeurosci 1997, 17:2295-2313.
18. Costas J., Sanjuán J., Ramos-Ríos R., Paz E., Agra S., Ivorra J.L., et al. Heterozygosity at catechol-O-methyltransferase Val158Met and schizophrenia: new data and meta-analysis. JPsychiatr Res 2011, 45:7-14.
19. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet 2013, 45:984-994. Cross-Disorder Group of the Psychiatric Genomics Consortium.
20. Curran S., Mill J., Tahir E., Kent L., Richards S., Gould A., et al. Association study of a dopamine transporter polymorphism and attention deficit hyperactivity disorder in UK and Turkish samples. Mol Psychiatry 2001, 6:425-428.
21. Davies W., Wilkinson L.S. It is not all hormones: alternative explanations for sexual differentiation of the brain. Brain Res 2006, 1126:36-45.
22. Domschke K., Deckert J., O'Donovan M.C., Glatt S.J. Meta-analysis of COMT val158met in panic disorder. Am J Med Genet Part B: Neuropsychiatr Genet 2007, 144B:667-673.
23. Ebejer J.L., Duffy D.L., van der Werf J., Wright M.J., Montgomery G., Gillespie N.A., et al. Genome-wide association study of inattention and hyperactivity-impulsivity measured as quantitative traits. Twin Res Hum Genet 2013, 16(2):560-574.
24. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003, 112:257-269.
25. Erhardt A., Akula N., Schumacher J., Czamara D., Karbalai N., Muller-Myhsok B., et al. Replication and meta-analysis of TMEM132D gene variants in panic disorder. Transl Psychiatry 2012, 2:e156.
26. Fakra E., Hyde L.W., Gorka A., Fisher P.M., Munoz K.E., Kimak M., et al. EFfects of htr1a c(-1019)g on amygdala reactivity and trait anxiety. Arch Gen Psychiatry 2009, 66:33-40.
27. Fan J.B., Zhang C., Gu N., Li X., Sun W., Wang H., et al. Catechol-O-Methyltransferase gene val/met functional polymorphism and risk of schizophrenia: a large-scale association study plus meta-analysis. Biol Psychiatry 2005, 57:139-144.
28. Fan M., Liu B., Jiang T., Jiang X., Zhao H., Zhang J. Meta-analysis of the association between the monoamine oxidase-A gene and mood disorders. Psychiatr Genet 2010, 20:1-7. 10.1097/YPG.0b013e3283351112.
29. Faraone S.V., Doyle A.E., Mick E., Biederman J. Meta-analysis of the association between the 7-repeat allele of the dopamine D4 receptor gene and attention deficit hyperactivity disorder. Am J Psychiatry 2001, 158:1052-1057.
30. Fiskerstrand C.E., Lovejoy E.A., Quinn J.P. An intronic polymorphic domain often associated with susceptibility to affective disorders has allele dependent differential enhancer activity in embryonic stem cells. FEBS Lett 1999, 458:171-174.
31. Frankenburg F.R. The role of one-carbon metabolism in schizophrenia and depression. Harv Rev Psychiatry 2007, 15:146-160.
32. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., et al. Acandidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995, 10:111-113.
33. Furlong R.A., Ho L., Rubinsztein J.S., Walsh C., Paykel E.S., Rubinsztein D.C. Analysis of the monoamine oxidase A (MAOA) gene in bipolar affective disorder by association studies, meta-analyses, and sequencing of the promoter. Am J Med Genet 1999, 88:398-406.
34. Furlong R.A., Ho L., Walsh C., Rubinsztein J.S., Jain S., Paykel E.S., et al. Analysis and meta-analysis of two serotonin transporter gene polymorphisms in bipolar and unipolar affective disorders. Am J Med Genet Part B: Neuropsychiatr Genet 1998, 81:58-63.
35. Gaysina D., Cohen S., Craddock N., Farmer A., Hoda F., Korszun A., et al. No association with the 5,10-methylenetetrahydrofolate reductase gene and major depressive disorder: results of the Depression Case Control (DeCC) study and meta-analysis. Am J Med Genet Part B: Neuropsychiatr Genet 2008, 147B:699-706.
36. Gilbody S., Lewis S., Lightfood T. Human genome epidemiology (HuGE) review: methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review. Am J Epidemiol 2006, 165:1-13.
37. Gizer I.R., Ficks C., Waldman I.D. Candidate gene studies of ADHD: a meta-analytic review. Hum Genet 2009, 126:51-90.
38. Glatt S.J., Faraone S.V., Tsuang M.T. Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies. Am J Psychiatry 2003, 16:469-476.
39. Glatt S.J., Wang R.S., Yeh Y., Tsuang M.T., Faraone S.V. Five NOTCH4 polymorphisms show weak evidence for association with schizophrenia: evidence from meta-analyses. Schizophr Res 2005, 73:281-290.
40. Goes F.S., Hamshere M.L., Seifuddin F., Pirooznia M., Belmonte-Mahon P., Breuer R., et al. Genome-wide association of mood-incongruent psychotic bipolar disorder. Transl Psychiatry 2012, 2:e180.
41. Gogos J.A., Morgan M., Luine V., Santha M., Ogawa S., Pfaff D.W., et al. Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci U S A 1998, 95:9991-9996.
42. Gore F.M., Bloem P.J.N., Patton G.C., Ferguson J., Joseph V., Coffey C., et al. Global burden of disease in young people aged 10-24 years: a systematic analysis. Lancet 2011, 377:2093-2102.
43. Gratacos M., Gonzalez J.R., Mercader J.M., de Cid R., Urretavizcaya M., Estivill X. Brain-derived neurotrophic factor val66met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia. Biol Psychiatry 2007, 61:911-922.
44. Harrison P.J., Tunbridge E.M. Catechol-O-methyltransferase (COMT): a gene contributing to sex differences in brain function, and to sexual dimorphism in the predisposition to psychiatric disorders. Neuropsychopharmacology 2008, 33:3037-3045.
45. Hart A.B., de Wit H., Palmer A.A. Candidate gene studies of a promising intermediate phenotype: failure to replicate. Neuropsychopharmacology 2013, 38:802-816.
46. Hattersley A.T., McCarthy M.I. What makes a good genetic association study?. Lancet 2005, 366:1315-1323.
47. Holmans P., Zubenko G., Crowe R., dePaulo J.R., Scheftner W.A., Weissman M.M., et al. Genomewide significant linkage to recurrent, early-onset major depressive disorder on chromosome 15q. Am J Psychiatry 2004, 74:1154-1167.
48. Hong J., Shu-Leong H., Tao X., Lap-Ping Y. Distribution of catechol-O-methyltransferase expression in human central nervous system. Neuroreport 1998, 9:2861-2864.
49. Huang J., Perlis R.H., Lee P.H., Rush A.J., Fava M., Sachs G.S., et al. Cross-disorder genomewide analysis of schizophrenia, bipolar disorder, and depression. Am J Psychiatry 2010, 167:1254-1263.
50. Ioannidis J.P.A., Ntzani E.E., Trikalinos T.A. 'Racial' differences in genetic effects for complex diseases. Nat Genet 2004, 36:1312-1318.
51. Jia P., Wang L., Fanous A.H., Pato C.N., Edwards T.L., The International Schizophrenia Consortium, et al. Network-assisted investigation of combined causal signals from genome-wide association studies in schizophrenia. PLoS Comput Biol 2012, 8:e1002587.
52. Jonsson E.G., Edman-Ahlbom B., Sillen A., Gunnar A., Kulle B., Frigessi A., et al. Brain-derived neurotrophic factor gene (BDNF) variants and schizophrenia: an association study. Prog Neuro-Psychopharmacol Biol Psychiatry 2006, 30:924-933.
53. Jonsson E.G., Flyckt L., Burgert E., Crocq M., Forslund K., Mattila-Evenden M., et al. Dopamine D3 receptor gene Ser9Gly variant and schizophrenia: association study and meta-analysis. Psychiatr Genet 2003, 13:1-12.
54. Kaminsky Z., Wang S.C., Petronis A. Complex disease, gender and epigenetics. Ann Med 2006, 38:530-544.
55. Kanazawa T., Glatt S.J., Kia-Keating B., Yoneda H., Tsuang M.T. Meta-analysis reveals no association of the val66met polymorphism of brain-derived neurotrophic factor with either schizophrenia or bipolar disorder. Psychiatr Genet 2007, 17:165-170.
56. Karg K., Burmeister M., Shedden K., Sen S. The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation. Arch General Psychiatry 2011, 68:444-454.
57. Kawashima K., Ikeda M., Kishi T., Kitajima T., Yamanouchi Y., Kinoshita Y., et al. BDNF is not associated with schizophrenia: data from a Japanese population study and meta-analysis. Schizophr Res 2009, 112:72-79.
58. Kelly S.J., Ostrowski N.L., Wilson M.A. Gender differences in brain and behavior: hormonal and neural bases. Pharmacol Biochem Behav 1999, 64:655-664.
59. Kessler R.C., Berglund P., Demler O., Jin R., Merikangas K.R., Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry 2005, 62:593-602.
60. Kim J.M., Kim S.W., Shin I.S., Yang S.J., Park W.Y., Kim S.J., et al. Folate, vitamin b(12), and homocysteine as risk factors for cognitive decline in the elderly. Psychiatry Investig 2008, 5:36-40.
61. Kim S., Song J.Y., Joo E.J., Jeong S.H., Kim S.H., Lee K.Y., et al. No association of functional polymorphisms in methlylenetetrahydrofolate reductase and the risk and minor physical anomalies of schizophrenia in Korean population. JKorean Med Sci 2011, 26:1356-1363.
62. Kiyohara C., Yoshimasu K. Association between major depressive disorder and a functional polymorphism of the 5-hydroxytryptamine (serotonin) transporter gene: a meta-analysis. Psychiatr Genet 2010, 20:49-52.
63. Krebs M.O., Bellon A., Mainguy G., Jay T.M., Frieling H. One-carbon metabolism and schizophrenia: current challenges and future directions. Trends Mol Med 2009, 15:562-570.
64. Kronenberg G., Colla M., Endres M. Folic acid, neurodegenerative and neuropsychiatric disease. Curr Mol Med 2009, 9:315-323.
65. Kyogoku C., Yanagi M., Nishimura K., Sugiyama D., Morinobu A., Fukutake M., et al. Association of calcineurin A gamma subunit (PPP3CC) and early growth response 3 (EGR3) gene polymorphisms with susceptibility to schizophrenia in a Japanese population. Psychiatry Res 2011, 185:16-19.
66. Lachman H.M., Papolos D.F., Saito T., Yu Y.M., Szumlanski C.L., Weinshilboum R.M. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996, 6:243-250.
67. Lasky-Su J.A., Faraone S.V., Glatt S.J., Tsuang M.T. Meta-analysis of the association between two polymorphisms in the serotonin transporter gene and affective disorders. Am J Med Genet Part B: Neuropsychiatr Genet 2005, 133B:110-115.
68. Lee K.Y., Joo E.J., Jeong S.H., Kang U.G., Roh M., Kim S.H., et al. No association between AKT1 polymorphism and schizophrenia: a case-control study in a Korean population and a meta-analysis. Neurosci Res 2010, 66:238-245.
69. Lee P.H., Perlis R.H., Jung J.Y., Byrne E.M., Rueckert E., Siburian R., et al. Multi-locus genome-wide association analysis supports the role of glutamatergic synaptic transmission in the etiology of major depressive disorder. Transl Psychiatry 2012, 2:e180.
70. Levinson D.F. Meta-analysis in psychiatric genetics. Curr Psychiatry Rep 2005, 7:143-151.
71. Lewis C.M., Ng M.Y., Butler A.W., Cohen-Woods S., Uher R., Pirlo K., et al. Genome-wide association study of major recurrent depression in the U.K. population. Am J Psychiatry 2010, 167:949-957.
72. Lewis S.J., Lawlor D.A., Smith G.D., Araya R., Timpson N.J., Day I.N.M., et al. The thermolabile variant of MTHFR is associated with depression in the British women's heart and health study and a meta-analysis. Mol Psychiatry 2006, 11:352-360.
73. Li D., Collier D.A., He L. Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia. Hum Mol Genet 2006, 15:1995-2002.
74. Li D., He L. Association study between the dystrobreven binding protein 1 gene (DTNBP1) and schizophrenia: a meta-analysis. Schizophr Res 2007, 96:112-118.
75. Li D., He L. Association study between the NMDA receptor 2B subunit gene (GRIN2B) and schizophrenia: a HuGE review and meta-analysis. Genet Med 2007, 9:4-8.
76. Li D., Sham P.C., Owen M.J., He L. Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD). Hum Mol Genet 2006, 15:2276-2284.
77. Liu Y., Blackwood D.H., Caesar S., de Geus E.J.C., Farmer A., Ferreira M.A.R., et al. Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder. Mol Psychiatry 2011, 16:2-4.
78. Lopez-Leon S., Janssens A.C.J.W., Gonzalez-Zuloeta Ladd A.M.G., del-Favero J., Claes S.J., Oostra B.A. Meta-analyses of genetic studies on major depressive disorder. Mol Psychiatry 2008, 13:772-785.
79. Lotrich F.E., Pollock B.G. Meta-analysis of serotonin transporter polymorphisms and affective disorders. Psychiatr Genet 2004, 14:121-129.
80. Lowe N., Kirley A., Hawi Z., Sham P., Wickham H., Kratochvil C.J., et al. Joint analysis of the DRD5 marker concludes association with attention-deficit/hyperactivity disorder confined to the predominantly inattentive and combined subtypes. Am J Hum Genet 2004, 74:348-356.
81. MacKenzie A., Quinn J. Aserotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo. Proc Natl Acad Sci U S A 1999, 96:15251-15255.
82. Maher B.S., Marazita M.L., Ferrell R.E., Vanyukov M.M. Dopamine system genes and attention deficit hyperactivity disorder: a meta-analysis. Psychiatr Genet 2002, 12:207-215.
83. Michaelhaugh S.K., Fiskerstrand C., Lovejoy E., Bannon M.J., Quinn J.P. The dopamine transporter gene (SLC6A3) variable number of tandem repeats domain enhances transcription in dopamine neurons. JNeurochem 2001, 79:1033-1038.
84. Mill J., Asherson P., Browes C., D'Souza U., Craig I. Expression of the dopamine transporter gene is regulated by the 3'-UTR VNTR: evidence from brain and lymphocytes using quantitative RT-PCR. Am J Med Genet 2002, 114:975-979.
85. Müller D.J., Zai C.C., Shinkai T., Strauss J., Kennedy J.L. Association between the DAOA/G72 gene and bipolar disorder and meta-analyses in bipolar disorder and schizophrenia. Bipolar Disord 2011, 13:198-207.
86. Munafo M.R., Attwood A.S., Flint J. Neureglin 1 genotype and schizophrenia. Schizophr Bull 2008, 34:9-12.
87. Munafo M.R., Bowes L., Clark T.G., Flint J. Lack of association of the COMT (Val158/108Met) gene and schizophrenia: a meta-analysis of case-control studies. Mol Psychiatry 2005, 10:765-770.
88. Munafo M.R., Thiselton D.L., Clark T.G., Flint J. Association of the NRG1 gene and schizophrenia: a meta-analysis. Mol Psychiatry 2006, 11:539-546.
89. Muntjewerff J.W., Kahn R.S., Blom H.J., den Heijer M. Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis. Mol Psychiatry 2006, 11:143-149.
90. Naoe Y., Shinkai T., Hori H., Fukunaka Y., Utsunomiya K., Sakata S., et al. No association between the brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and schizophrenia in Asian populations: evidence from a case-control study and meta-analysis. Neurosci Lett 2007, 415:108-112.
91. Neale B.M., Medland S.E., Ripke S., Asherson P., Franke B., Lesch K.-P., et al. Meta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorder. JAm Acad Child Adolesc Psychiatry 2010, 49:884-897.
92. Nestler E.J. Epigenetic mechanisms in psychiatry. Biol Psychiatry 2009, 65:189-190.
93. Nikolaidis A., Gray J.R. ADHD and the DRD4 exon III 7-repeat polymorphism: an international meta-analysis. SCAN 2010, 5:188-193.
94. Ohi K., Hashimoto R., Yasuda Y., Yoshida T., Takahashi H., Iike N., et al. The chitinase 3-like 1 gene and schizophrenia: evidence from a multi-centre case-control study and meta-analysis. Schizophr Res 2010, 116:126-132.
95. Okochi T., Ikeda M., Kishi T., Kawashima K., Kinoshita Y., Kitajima T., et al. Meta-analysis of association between genetic variants in COMT and schizophrenia: an update. Schizophr Res 2009, 110:140-148.
96. Otowa T., Kawamura Y., Nishida N., Sugaya N., Koike A., Yoshida E., et al. Meta-analysis of genome-wide association studies for panic disorder in the Japanese population. Transl Psychiatry 2012, 2:e180.
97. Pasca S.P., Dronca E., Kaucsar T., Craciun E.C., Endreffy E., Ferencz B.K., et al. One carbon metabolism disturbances and the C677T MTHFR gene polymorphism in children with autism spectrum disorders. JCell Mol Med 2009, 13:4229-4238.
98. Peerbooms O.L.J., van Os J., Drukker M., Kenis G., Hoogveld L., de Hert M., et al. Meta-analysis of MTHFR gene variants in schizophrenia, bipolar disorder and unipolar depressive disorder: evidence for a common genetic vulnerability?. Brain Behav Immun 2011, 25:1530-1543.
99. Piccinelli M., Wilkinson G. Gender differences in depression - criticial review. Br J Psychiatry 2000, 177:486-492.
100. Pinsonneault J.K., Papp A.C., Sadee W. Allelic mRNA expression of X-linked monoamine oxidase a (MAOA) in human brain: dissection of epigenetic and genetic factors. Hum Mol Genet 2006, 15:2636-2649.
101. Polanczyk G., de Lima M.S., Horta B.L., Biederman J., Rohde L.A. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 2007, 164:942-948.
102. Pooley E.C., Fineberg N., Harrison P.J. The met158 allele of catechol-O-methyltransferase (COMT) is associated with obsessive-compuslive disorder in men: case-control study and meta-analysis. Mol Psychiatry 2007, 12:556-561.
103. Preisig M., Bellivier F., Fenton B.T., Baud P., Berney A., Courtet P., et al. Association between bipolar disorder and monoamine oxidase A gene polymorphisms: results of a multicenter study. Am J Psychiatry 2000, 157:948-955.
104. Prince M., Patel V., Saxena S., Maj M., Maselko J., Phillips M.R., et al. No health without mental health. Lancet 2007, 370:859-877.
105. Purcell S.M., Wray N.R., Stone J.L., Visscher P.M., O'Donovan M.C., Sullivan P.F., et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009, 460:748-752.
106. Purper-Ouakil D., Wohl M., Mouren M.C., Verpillat P., Ades J., Gorwood P. Meta-analysis of family-based association studies between the dopamine transporter gene and attention deficit hyperactivity disorder. Psychiatr Genet 2005, 15:53-59.
107. Qian L., Zhao J., Shi Y., Zhao X., Geng G., Xu F., et al. Brain-derived neurotrophic factor and risk of schizophrenia: an association study and meta-analysis. Biochem Biophys Res Commun 2007, 353:738-743.
108. Rai V. Evaluation of methylenetetrahydrofolate reductase gene variant (C677T) as risk factor for bipolar disorder. Cell Mol Biol 2011, 57:1558-1566.
109. Rattiner L.M., Davis M., French C.T., Ressler K.J. Brain-derived neurotrophic factor and tyrosine kinase receptor B involvement in amygdala-dependent fear conditioning. JNeurosci 2004, 24:4796-4806.
110. Reist C., Ozdemir V., Wang E., Hashemzadeh M., Mee S., Moyzis R. Novelty seeking and the dopamine D4 receptor gene (DRD4) revisited in Asians: haplotype characterisation and relevance of the 2-repeat allele. Am J Med Genet Part B: Neuropsychiatr Genet 2007, 144:453-457.
111. Risch N., Herrell R., Lehner T., Liang K., Eaves L., Hoh J., et al. Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. JAm Med Assoc 2009, 301:2462-2471.
112. Rubinow D.R., Schmidt P.J. Androgens, brain, and behavior. Am J Psychiatry 1996, 153:974-984.
113. Rubinsztein D.C., Leggo J., Goodburn S., Walsh C., Jain S., Paykel E.S. Genetic association between monoamine oxidase A microsatellite and RFLP alleles and bipolar affective disorder: analysis and meta-analysis. Hum Mol Genet 1996, 5:779-782.
114. Saetre P., Lundmark P., Wang A., Hansen T., Rasmussen H.B., Djurovic S., et al. The tryptophan hydroxylase 1 (TPH1) gene, schizophrenia susceptibility, and suicidal behaviour: a multi-centre case-control study and meta-analysis. Am J Med Genet Part B: Neuropsychiatr Genet 2009, 153B:387-396.
115. Schurhoff F., Krebs M., Szoke A., Loze J., Goldberger C., Quignon V., et al. Apolipoprotein E in schizophrenia: a French association study and meta-analysis. Am J Med Genet Part B: Neuropsychiatr Genet 2003, 119B:18-23.
116. Seeman M. Psychopathology in women and men: focus on female hormones. Am J Psychiatry 1997, 154:1641-1647.
117. Seifuddin F., Mahon P.B., Judy J., Pirooznia M., Jancic D., Taylor J., et al. Meta-analysis of genetic association studies on bipolar disorder. Am J Med Genet Part B: Neuropsychiatr Genet 2012, 159B:508-518.
118. Serretti A., Fabbri C. Shared genetics among major psychiatric disorders. Lancet 2013, 381:1339-1341.
119. Sheppard D.M., Bradshaw J.L., Purcell R., Pantelis C. Tourette's and comorbid syndromes: obsessive compulsive and attention deficit hyperactivity disorder. a common etiology?. Clin Psychol Rev 1999, 19:531-552.
120. Shi J., Badner J.A., Gershon E.S., Liu C. Allelic association of G72/G30 with schizophrenia and bipolar disorder: a comprehensive meta-analysis. Schizophr Res 2008, 98:89-97.
121. Shi J., Badner J.A., Gershon E.S., Liu C. Genetic associations with schizophrenia: meta-analyses of 12 candidate genes. Schizophr Res 2008, 104:96-107.
122. Shi J., Badner J.A., Liu C. PDLIM5 and susceptibility to bipolar disorder: a family-based association study and meta-analysis. Psychiatr Genet 2008, 18:116-121.
123. Shi J., Levinson D.F., Duan J., Sanders A.R., Zheng Y., Pe'er I., et al. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 2009, 460:753-757.
124. Shiroiwa K., Hishimoto A., Mouri K., Fukutake M., Supriyanto I., Nishiguchi N., et al. Common genetic variations in TPH1/TPH2 genes are not associated with schizophrenia in Japanese population. Neurosci Lett 2010, 472:194-198.
125. Shyn S.I., Shi J., Kraft J.B., Potash J.B., Knowles J.A., Weissman M.M., et al. Novel loci for major depression identified by genome-wide association study of sequenced treatment alternatives to relieve depression and meta-analysis of three studies. Mol Psychiatry 2011, 16:202-215.
126. Sivakumaran S., Agakov F., Theodoratou E., Prendergast J.G., Zgaga L., Manolio T., et al. Abundant pleiotrophy in human complex diseases and traits. Am J Hum Genet 2011, 89:607-618.
127. Smith T.F. Meta-analysis of the heterogeneity in association of DRD4 7-repeat allele and AD/HD: stronger association with AD/HD combined type. Am J Med Genet Part B: Neuropsychiatr Genet 2010, 153B:1189-1199.
128. Smoller J.W., Kendler K.S., Craddock N. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 2013, 381:1371-1379. Consortium C-DGotPG.
129. Smulders Y.M., Stehouwer C.D. Folate metabolism and cardiovascular disease. Semin Vasc Med 2005, 5:87-97.
130. Sugden C. One-carbon metabolism in psychiatric illness. Nutr Res Rev 2006, 19:117-136.
131. Sullivan P.F. Spurious genetic associations. Biol Psychiatry 2007, 61:1121-1126.
132. Terwisscha van Scheltinga A.F., Bakker S.C., van Haren N.E., Derks E.M., Buizer-Voskamp J.E., Boos H.B., et al. Genetic schizophrenia risk variants jointly modulate total brain and white matter volume. Biol Psychiatry 2013, 73:525-531.
133. Thomas D.C., Witte J.S. Point: population stratification: a problem for case-control studies of candidate-gene associations?. Cancer Epidemiol Biomark Prev 2002, 11:505-512.
134. Uchida N., Ujike H., Nakata K., Takaki M., Nomura A., Katsu T., et al. No association between the sigma receptor type I gene and schizophrenia: results of analysis and meta-analysis of case-control studies. BMC Psychiatry 2003, 3:13.
135. van der Put N.M., Gabreels F., Stevens E.M., Smeitink J.A., Trijbels F.J., Eskes T.K., et al. Asecond common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?. Am J Hum Genet 1998, 62:1044-1051.
136. van der Put N.M., van Straaten H.W., Trijbels F.J., Blom H.J. Folate, homocysteine and neural tube defects: an overview. Exp Biol Med 2001, 226:243-270.
137. van Schijndel J.E., van Loo K.M.J., van Zweeden M., Djurovic S., Andreassen O.A., Hansen T., et al. Three-cohort targeted gene screening reveals a non-synonymous TRKA polymorphism associated with schizophrenia. JPsychiatr Res 2009, 43:1195-1199.
138. Vawter M.P., Evans S., Choudary P., Tomita H., Meador-Woodruff J., Molnar M., et al. Gender-specific gene expression in post-mortem human brain: localization to sex chromosomes. Neuropsychopharmacology 2004, 29:373-384.
139. Wang K.-S., Liu X.-F., Aragam N. Agenome-wide meta-analysis identifies novel loci associated with schizophrenia and bipolar disorder. Schizophr Res 2010, 124:192-199.
140. Wang K.S., Zhang Q., Liu X., Wu L., Zeng M. PKNOX2 is associated with formal thought disorder in schizophrenia: a meta-analysis of two genome-wide association studies. JMol Neurosci 2012, 48:265-272.
141. Wantanabe Y., Nunokawa A., Kaneko N., Someya T. Meta-analysis of case-control association studies between the C270T polymorphism of the brain-derived neurotrophic factor gene and schizophrenia. Schizophr Res 2007, 95:250-252.
142. Wray N.R., Pergadia M.L., Blackwood D.H.R., Penninx B.W.J.H., Gordon S.D., Nyholt D.R., et al. Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learned. Mol Psychiatry 2012, 17:36-48.
143. Wu Y., Wang X., Shen X., Tan Z., Yuan Y. The I/D polymorphism of angiotensin-converting enzyme gene in major depressive disorder and therapeutic outcome: a case-control study and meta-analysis. JAffect Disord 2012, 136:971-978.
144. Xu M., St Clair D., He L. Meta-analysis of association between ApoE E4 allele and schizophrenia. Schizophr Res 2006, 84:228-235.
145. Xu M., St Clair D., Ott J., Feng G., He L. Brain-derived neurotrophic factor gene C-270T and val66met functional polymorphisms and risk of schizophrenia: a moderate-scale population-based study and meta-analysis. Schizophr Res 2007, 91:6-13.
146. Yang B., Chan R.C.K., Jing J., Li T., Sham P., Chen R.Y.L. Ameta-analysis of association studies between the 10-repeat allele of a VNTR polymorphism in th 3'-UTR of dopamine transporter gene and attention deficit hyperactivity disorder. Am J Med Genet Part B: Neuropsychiatr Genet 2007, 144B:541-550.
147. Yoshimi A., Aleksic B., Kawamura Y., Takahashi N., Yamada S., Usui H., et al. Gene-wide association study between the methylenetetrahydrofolate reductase gene (MTHFR) and schizophrenia in the Japanese population, with an updated meta-analysis on currently available data. Schizophr Res 2010, 124:216-222.
148. Young S.N., Leyton M. The role of serotonin in human mood and social interaction: insight from altered tryptophan levels. Pharmacol Biochem Behav 2002, 71:857-865.
149. Zhang H.Y., Luo G.A., Liang Q.L., Wang Y.M., Zheng X.Y., Song X.M., et al. Neural tube defects and disturbed maternal folate- and homocysteine-mediated one-carbon matebolism. Exp Neurol 2008, 212:515-521.
150. Zintzaras E. C677T and A1298C methylenetetrahydrofolate reductase gene polymorphisms in schizophrenia, bipolar disorder and depression: a meta-analysis of genetic association studies. Psychiatr Genet 2006, 16:105-115.
151. Zintzaras E.R.G.,K.G.L.J, Angiotensin-converting enzyme insertion/deletion gene polymorphic variant as a marker of coronary artery disease: a meta-analysis. Arch Intern Med 2008, 168:1077-1089.
152. Zintzaras E., Sakelaridis N. Is 472G/A catechol-O-methyl-transferase gene polymorphis related to panic disorder?. Psychiatr Genet 2007, 17:267-273.